Top Markets
Coin of the day
Yumanity Therapeutics, Inc. Yumanity Therapeutics, Inc.

Yumanity Therapeutics, Inc.

YMTX
Classifica tra le azioni #28846
Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical... Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical company. Its primary focus lies in the investigation and development of therapeutic solutions for neurodegenerative conditions, particularly those driven by protein misfolding. The firm aims to discover disease-modifying treatments for a range of neurodegenerative disorders, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis (ALS), and frontotemporal lobar degeneration. Central to its pipeline is YTX-7739, an innovative small molecule presently in Phase I clinical trials for Parkinson's disease and associated α-synuclein disorders. Additionally, YTX-9184 is undergoing preclinical studies with the goal of treating diverse neurological conditions. The company maintains a license and research collaboration agreement with Merck Sharp & Dohme Corp. Founded in 2014, Yumanity Therapeutics Inc. is headquartered in Boston, Massachusetts.
Prezzo delle azioni
$1.89
Ultima sincronizzazione: 2022-12-16
Capitalizzazione di mercato
$24.38M
Variazione (1 giorno)
8.62%
Variazione (1 anno)
0.00%
Paese
US
Scambia Yumanity Therapeutics, Inc. (YMTX)

Categoria

Il prezzo YMTX con la capitalizzazione del mercato della B
Yumanity Therapeutics, Inc. Yumanity Therapeutics, Inc.
YMTX
$1.89
Capitalizzazione di mercato di Yumanity Therapeutics, Inc.(YMTX)
Capitalizzazione di mercato: $24.38M
A partire dal August 2026, Yumanity Therapeutics, Inc. ha una capitalizzazione di mercato pari a $24.38M. Questo rende Yumanity Therapeutics, Inc. la 28846th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Yumanity Therapeutics, Inc. dal 2020 al 2026
YMTX in paragone con la classifica dei più popolari stocks
Il prezzo per YMTX Attivo B Capitalizzazione del mercato a B Risultati
Yumanity Therapeutics, Inc. Yumanity Therapeutics, Inc.
$410,830 $24.38M
$5.301T +21,736,916.45%
Yumanity Therapeutics, Inc. Yumanity Therapeutics, Inc.
$359,136 $24.38M
$4.634T +19,001,781.79%
Yumanity Therapeutics, Inc. Yumanity Therapeutics, Inc.
$321,104 $24.38M
$4.143T +16,989,555.26%
Yumanity Therapeutics, Inc. Yumanity Therapeutics, Inc.
$278,185 $24.38M
$3.589T +14,718,669.63%
Yumanity Therapeutics, Inc. Yumanity Therapeutics, Inc.
$221,420 $24.38M
$2.857T +11,715,252.97%